Diabetic retinopathy: Looking forward to 2030

TE Tan, TY Wong - Frontiers in Endocrinology, 2023 - frontiersin.org
Diabetic retinopathy (DR) is the major ocular complication of diabetes mellitus, and is a
problem with significant global health impact. Major advances in diagnostics, technology …

Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications—risks and mitigation

M Kropp, O Golubnitschaja, A Mazurakova… - Epma Journal, 2023 - Springer
Proliferative diabetic retinopathy (PDR) the sequel of diabetic retinopathy (DR), a frequent
complication of diabetes mellitus (DM), is the leading cause of blindness in the working-age …

Integrated image-based deep learning and language models for primary diabetes care

J Li, Z Guan, J Wang, CY Cheung, Y Zheng, LL Lim… - Nature medicine, 2024 - nature.com
Primary diabetes care and diabetic retinopathy (DR) screening persist as major public
health challenges due to a shortage of trained primary care physicians (PCPs), particularly …

American Association of Clinical Endocrinology clinical practice guideline: develo** a diabetes mellitus comprehensive care plan—2022 update

L Blonde, GE Umpierrez, SS Reddy, JB McGill… - Endocrine Practice, 2022 - Elsevier
Objective The objective of this clinical practice guideline is to provide updated and new
evidence-based recommendations for the comprehensive care of persons with diabetes …

Classification of diabetic retinopathy: Past, present and future

Z Yang, TE Tan, Y Shao, TY Wong, X Li - Frontiers in endocrinology, 2022 - frontiersin.org
Diabetic retinopathy (DR) is a leading cause of visual impairment and blindness worldwide.
Since DR was first recognized as an important complication of diabetes, there have been …

[HTML][HTML] Optical coherence tomography angiography in diabetic retinopathy

NK Waheed, RB Rosen, Y Jia, MR Munk… - Progress in retinal and …, 2023 - Elsevier
There remain many unanswered questions on how to assess and treat the pathology and
complications that arise from diabetic retinopathy (DR). Optical coherence tomography …

[HTML][HTML] Central serous chorioretinopathy: An evidence-based treatment guideline

HMA Feenstra, EHC Van Dijk, CMG Cheung… - Progress in Retinal and …, 2024 - Elsevier
Central serous chorioretinopathy (CSC) is a relatively common disease that causes vision
loss due to macular subretinal fluid leakage and it is often associated with reduced vision …

The blood–retina barrier in health and disease

F O'Leary, M Campbell - The FEBS Journal, 2023 - Wiley Online Library
The blood–retina barrier (BRB) is the term used to define the properties of the retinal
capillaries and the retinal pigment epithelium (RPE), which separate the systemic circulation …

Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy

X Lu, Q **e, X Pan, R Zhang, X Zhang… - … and Targeted Therapy, 2024 - nature.com
Abstract Type 2 diabetes (T2D) is a disease characterized by heterogeneously progressive
loss of islet β cell insulin secretion usually occurring after the presence of insulin resistance …

Artificial intelligence and diabetic retinopathy: AI framework, prospective studies, head-to-head validation, and cost-effectiveness

AE Rajesh, OQ Davidson, CS Lee, AY Lee - Diabetes care, 2023 - diabetesjournals.org
Current guidelines recommend that individuals with diabetes receive yearly eye exams for
detection of referable diabetic retinopathy (DR), one of the leading causes of new-onset …